ArticleNPJ systems biology and applications2025
Identifying genes underlying parallel evolution of stromal resistance to placental and cancer invasion.
Article in NPJ systems biology and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Stromal regulation of cancer dissemination is well recognized, however causal genes remain unidentified. We previously demonstrated that epitheliochorial species have acquired stromal resistance to placental invasion, correlating with reduced rate of cancer malignancies, identifying stromal genes correlating with depth of placental invasion called ELI (Evolved Levels of Invasibility) genes. Similarly, decidualization of human endometrial fibroblasts confers resistance to placental invasion. We hypothesized that both trajectories may convergently use similar pathways, providing an opportunity to identify stromal genes regulating epithelial invasion. We created a gene-set ELI-D1 (ELI-Decidual 1), putatively underlying stromal vulnerability to invasion. ELI-D1 were negatively enriched in T1-T2 stage transition in many human cancers, typically preceding dissemination. We also identified candidate transcriptional regulators underlying variation in ELI-D1 genes across eutherians, functionally showing Nr2f6, and JDP2 can regulate stromal resistance to invasion in human fibroblasts. Our comparative approach provides us with a gene-set linked to stromal vulnerability in human cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.